BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16944747)

  • 1. [Monitoring of minimal residual disease in patients with acute promyelocytic leukemia].
    Shuravina EN; Parovichnikova EN; Demidova IA; Misiurin AV; Isaev VG; Ol'shanskaia IuV; Savchenko VG
    Ter Arkh; 2006; 78(7):25-31. PubMed ID: 16944747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].
    Parovichnikova EN; Savchenko VG; Demidova IA; Isaev VG; Shuravina EN; Ustinova EN; Gribanova EO; Aleksanian MZh; Misiurin AV; Domracheva EV; Ol'shanskaia IuV; Khoroshko ND; Kravchenko SK; Konstantinova TS; Anchukova LV; Kaplanov K; Zagoskina TP; Volkova SA; Filatov LB; Rekhtman GB; Sokolova I; Mashuk VN; Miliutina GI; Lapin VA; Perekatova TN; Sviridova EI; Pristupa AS; Ziuzgin IS
    Ter Arkh; 2004; 76(7):11-8. PubMed ID: 15379121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
    Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S
    Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
    Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
    George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
    Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemia.
    Karlic HI; Mühlberger H; Pavlova BG; Pfeilstöcker M; Salamon J; Pittermann E; Heinz R; Koller E
    Bone Marrow Transplant; 1995 Jun; 15(6):999-1000. PubMed ID: 7581106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
    Martinelli G; Ottaviani E; Visani G; Testoni N; Montefusco V; Tura S
    Haematologica; 1998 Sep; 83(9):860-3. PubMed ID: 9825588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].
    Savchenko VG; Parovichnikova EN; Isaev VG; Shuravina EN; Demidova IA; Ol'shanskaia IuV
    Ter Arkh; 2002; 74(7):11-8. PubMed ID: 12181827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trial.
    Lee S; Kim YJ; Eom KS; Min CK; Kim HJ; Cho SG; Lee JW; Min WS; Kim CC
    Haematologica; 2006 May; 91(5):671-4. PubMed ID: 16627255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment concepts of acute promyelocytic leukemia.
    Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ; Morales-Toquero A; Gómez-Rangel JD; López-Martínez B; Ruiz-Delgado GJ; Reyes-Núñez V
    Rev Invest Clin; 2005; 57(3):415-9. PubMed ID: 16187701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular responses in acute promyelocytic leukemia patients monitored by real-time quantitative RT-PCR].
    Yao L; Chen ZX; Cen JN
    Ai Zheng; 2008 Feb; 27(2):214-7. PubMed ID: 18279625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.